MGIC Investment Corporation (MTG) grew with the stock adding 3.01% or $0.3 to close at $10.27 on active trading volume of 8.32M compared its three months average trading volume of 5.28M. The Milwaukee Wisconsin 53202 based company operating under the Property & Casualty Insurance industry has been trending up for the last 52 weeks, with the shares price now 40.11% up for the period and up by 0.79% so far this year. With price target of $11.4 and a 91.6% rebound from 52-week low, MGIC Investment Corporation has plenty of upside potential, making it a hold with a view buy.
MGIC Investment Corporation, through its subsidiaries, provides private mortgage insurance and ancillary services to lenders and government sponsored entities in the United States. The company offers primary mortgage insurance that provides mortgage default protection on individual loans, as well as covers unpaid loan principal, delinquent interest, and various expenses associated with the default and subsequent foreclosure. It also provides contract underwriting services; and other services for the mortgage finance industry, such as analysis of loan originations and portfolios, and mortgage lead generation services. In addition, the company participates in external reinsurance arrangements and captive mortgage reinsurance arrangements. It serves originators of residential mortgage loans, including savings institutions, commercial banks, mortgage brokers, credit unions, mortgage bankers, and other lenders. The company was founded in 1957 and is headquartered in Milwaukee, Wisconsin.
Merck & Co., Inc. (MRK) had a active trading with around 8.12M shares changing hands compared to its three month average trading volume of 11.12M. The stock traded between $61.08 and $61.78 before closing at the price of $61.17 with -0.5% change on the day. The Kenilworth New Jersey 07033 based company is currently trading 31.64% above its 52 week low of $47.97 and -5.84% below its 52 week high of $65.46. Both the RSI indicator and target price of and $0 respectively, lead us to believe that it could rise over the coming weeks.
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; non-sedating antihistamine; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; chewable tablets to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures to develop molecule compounds for various cancer treatments. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Sanchez Energy Corporation (SN) saw its value increase by 0.76% as the stock gained $0.1 to finish the day at a closing price of $13.3. The stock was higher in trading and has fluctuated between $2.06-$13.68 per share for the past year. The shares, which traded within a range of $12.71 to $13.66 during the day, are up by 85.24% in the past three months and up by 108.14% over the past six months. It is currently trading 39.44% above its 20 day moving average and 55.97% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $9.3 a share over the next twelve months. The current relative strength index (RSI) reading is 79.35.The technical indicator do not lead us to believe the stock will see more gains any time soon.
Sanchez Energy Corporation, an independent exploration and production company, engages in the exploration, acquisition, and development of oil and natural gas resources in the onshore U.S. Gulf Coast. It holds a 93% working interest in the Eagle Ford Shale, which consists of approximately 200,000 net leasehold acres in the oil and condensate, or black oil and volatile oil located in South Texas; and a 65% working interest in the Tuscaloosa Marine Shale covering an area of approximately 62,000 net leasehold acres situated in Mississippi and Louisiana. The company was founded in 2011 and is headquartered in Houston, Texas.